$136.53
-0.46-0.34%
At close: -
$137.24
0.710.52%
After Hours: 4:00 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Neurocrine Biosciences in recent months.
Browse guidance and forecast on all stocks.